                         SEQUENCE LISTING

<110>  North Carolina State University
       Menegatti, Stefano
       Xiao, Xingqing
       Hall, Carol K.
       Reese, Hannah
 
<120>  IMMUNOGLOBULIN PURIFICATION PEPTIDES AND THEIR USE

<130>  5051.968.WO

<150>  US 62/912,118
<151>  2019-10-08

<160>  34    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  1

Trp Gln Arg His Gly Ile 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  2

Met Trp Arg Gly Trp Gln 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  3

Arg His Leu Gly Trp Phe 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  4

Gly Trp Leu His Gln Arg 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  5

Met Trp Arg Ala Trp Gln 
1               5       


<210>  6
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  6

Met Trp Arg Trp Gln 
1               5   


<210>  7
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  7

Met Trp Arg Gly Phe Gln 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  8

Gly Trp Arg Gly Trp Gln 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  9

Trp Gln Arg His Gly Leu 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  10

Trp Gln Arg His Gly Val 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  11

Trp Gln Arg His Ala Ile 
1               5       


<210>  12
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  12

Trp Asn Arg His Gly Ile 
1               5       


<210>  13
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  13

Arg Met Trp Gly Trp Asn 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  14

Trp His Arg Leu Gln Gly 
1               5       


<210>  15
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  15

Trp His Arg Gly Gln Leu 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  16

His Trp Arg Gly Trp Trp 
1               5       


<210>  17
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  17

His Trp Arg Gly Leu Gln 
1               5       


<210>  18
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  18

His Trp Arg Gly Trp Val 
1               5       


<210>  19
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  19

Gly Trp Leu His Trp Gln Arg 
1               5           


<210>  20
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  wherein Xaa is citrulline

<400>  20

His Trp Xaa Gly Trp Val 
1               5       


<210>  21
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  21

Met Phe Arg Gly Trp Gln 
1               5       


<210>  22
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  22

Met Trp Arg Gly Trp Asn 
1               5       


<210>  23
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein Xaa is nor-leucine

<400>  23

Xaa Trp Arg Gly Trp Gln 
1               5       


<210>  24
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  24

Met Gly Arg Gly Trp Gln 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  wherein Xaa is citrulline

<400>  25

Met Trp Xaa Gly Trp Gln 
1               5       


<210>  26
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  26

Met Trp Arg Gly Gly Gln 
1               5       


<210>  27
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  wherein Xaa is citrulline

<400>  27

Trp Gln Xaa His Gly Ile 
1               5       


<210>  28
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  28

Trp Gln Arg Ala Gly Ile 
1               5       


<210>  29
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  29

Phe Gln Arg His Gly Ile 
1               5       


<210>  30
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  30

Trp Gln Arg His Gly Ile Cys 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  31

Met Trp Arg Gly Trp Gln Cys 
1               5           


<210>  32
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  32

Trp Gln Arg Gly His Ile Cys 
1               5           


<210>  33
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  33

Trp Gln Arg His Ile 
1               5   


<210>  34
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  34

His Trp Arg Gly Trp Val Cys 
1               5           


